AI assistant
Sending…
BIOXYNE LIMITED — Capital/Financing Update 2007
Mar 22, 2007
64594_rns_2007-03-22_332da67d-059c-4f26-a5d2-c5c1e32085c4.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer


Problomics Limited ABN 97-084-464-193
Suite G09, 1 Central Avenue Australian Technology Park Eveleigh NSW 1430
$P: +61292094268$ $F: +61292094256$ W: www.probiomies.com.au
The Australian Stock Exchange Limited, Companies Announcements Office, SYDNEY Via: asxonline 23 March 2007
Dear Sirs,
The Board of Directors of Probiomics Limited (ASX code: PCC) is pleased to announce a capital raising of \$400,000 by way of a private placement of shares at \$0.035c per share to a group of 'sophisticated' investors. The placement is made pursuant to ASIC class order 02/1180.
An appendix 3B will follow shortly.
Yours sincerely,
Anopfi
Paul B Magoffin, Company Secretary
More from BIOXYNE LIMITED
Director's Dealing
2026
Jun 5
Board/Management Information
2026
Jun 3
Investor Presentation
2026
Jun 1
Share Issue/Capital Change
2026
May 25
Share Issue/Capital Change
2026
May 20
Proxy Solicitation & Information Statement
2026
May 20
Proxy Solicitation & Information Statement
2026
May 20
Share Issue/Capital Change
2026
May 19
Director's Dealing
2026
May 14
Regulatory Filings
2026
May 11